MedTrace Logo

Left Ventricular Mass Index Predicts Clinical Outcomes in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy

NCT06609382 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 490

Last updated 2024-09-24

No results posted yet for this study

Summary

In this study, we aimed to analyze the association between left ventricular mass index and clinical outcomes to provide the potential indicator for worse survival.

Conditions

  • Obstructive Hypertrophic Cardiomyopathy (oHCM)

Interventions

OTHER

Patients had a higher left ventricular mass index or not （the exact value is determined by the cut-off value for the clinical outcomes)

Patients were grouped by the cutoff value of left ventricular mass index (LVMI) for all cause death, and the Maximally Selected Rank Statistics method was used to determine the optimal cutoff point of LVMI for death.

Sponsors & Collaborators

  • Changrong Nie

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06609382 on ClinicalTrials.gov